Brief: Swedish Orphan Biovitrum Keeps Outlook 2026 Unchanged
April 28 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST: SOBI Q1 ADJUSTED FREE CASH FLOW SEK 1,126 MILLION SOBI Q1 REVENUE SEK 7,184 MILLION VERSUS. IBES ESTIMATE SEK 7,152 MILLION SOBI Q1 EBIT SEK 1,868 MILLION VERSUS. IBES ESTIMATE SEK 1,793 MILLION SOBI Q1 ADJUSTED EPS SEK 3.81 SWEDISH ORPHAN BIOVITRUM - OUTLOOK 2026 UNCHANGED Source text: ID:nWkr90Ryd8 Further company coverage: SOBIV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Swedish Orphan Biovitrum AB (publ)
See all newsTop of the Street: SOBI, Sonova, BAT, Imperial Brands
SOBI slips after Ionis lowers Tryngolza sales forecast
Brief: Swedish Orphan Biovitrum Executive Sells, Buys Shares
Europe Research Roundup: Centrica, Fuchs, URW
Brief: Swedish Orphan Biovitrum Proposes Börje Ekholm As New Chair And Board Member At 2027 AGM